Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actonel dosing satisfaction in postmenopausal osteoporosis
NCT00549965Phase 4Completed
- Sponsor
- Sanofi
- Start
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate in osteoporosis, sponsored by Sanofi. Started Oct 2003; status: completed.
02
Drugs
risedronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00549965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549965.